Cargando…

Asian Conference on Tumor Ablation guidelines for renal cell carcinoma

Thermal ablation has been established as an alternative treatment for renal cell carcinoma (RCC) in patients who are poor candidates for surgery. However, while American and European guidelines have been established for American and European patients, respectively, no ablation guidelines for Asian p...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Byung Kwan, Shen, Shu-Huei, Fujimori, Masashi, Wang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246015/
https://www.ncbi.nlm.nih.gov/pubmed/34190433
http://dx.doi.org/10.4111/icu.20210168
_version_ 1783716224848363520
author Park, Byung Kwan
Shen, Shu-Huei
Fujimori, Masashi
Wang, Yi
author_facet Park, Byung Kwan
Shen, Shu-Huei
Fujimori, Masashi
Wang, Yi
author_sort Park, Byung Kwan
collection PubMed
description Thermal ablation has been established as an alternative treatment for renal cell carcinoma (RCC) in patients who are poor candidates for surgery. However, while American and European guidelines have been established for American and European patients, respectively, no ablation guidelines for Asian patients with RCCs have been established many years after the Asian Conference on Tumor Ablation (ACTA) had been held. Given that Western guidelines are difficult to apply to Asian patients due to differences in body habitus, economic status, and insurance systems, the current review sought to establish the first version of the ACTA guidelines for treating a RCC with thermal ablation.
format Online
Article
Text
id pubmed-8246015
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Urological Association
record_format MEDLINE/PubMed
spelling pubmed-82460152021-07-06 Asian Conference on Tumor Ablation guidelines for renal cell carcinoma Park, Byung Kwan Shen, Shu-Huei Fujimori, Masashi Wang, Yi Investig Clin Urol Review Article Thermal ablation has been established as an alternative treatment for renal cell carcinoma (RCC) in patients who are poor candidates for surgery. However, while American and European guidelines have been established for American and European patients, respectively, no ablation guidelines for Asian patients with RCCs have been established many years after the Asian Conference on Tumor Ablation (ACTA) had been held. Given that Western guidelines are difficult to apply to Asian patients due to differences in body habitus, economic status, and insurance systems, the current review sought to establish the first version of the ACTA guidelines for treating a RCC with thermal ablation. The Korean Urological Association 2021-07 2021-06-24 /pmc/articles/PMC8246015/ /pubmed/34190433 http://dx.doi.org/10.4111/icu.20210168 Text en © The Korean Urological Association, 2021 https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Park, Byung Kwan
Shen, Shu-Huei
Fujimori, Masashi
Wang, Yi
Asian Conference on Tumor Ablation guidelines for renal cell carcinoma
title Asian Conference on Tumor Ablation guidelines for renal cell carcinoma
title_full Asian Conference on Tumor Ablation guidelines for renal cell carcinoma
title_fullStr Asian Conference on Tumor Ablation guidelines for renal cell carcinoma
title_full_unstemmed Asian Conference on Tumor Ablation guidelines for renal cell carcinoma
title_short Asian Conference on Tumor Ablation guidelines for renal cell carcinoma
title_sort asian conference on tumor ablation guidelines for renal cell carcinoma
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246015/
https://www.ncbi.nlm.nih.gov/pubmed/34190433
http://dx.doi.org/10.4111/icu.20210168
work_keys_str_mv AT parkbyungkwan asianconferenceontumorablationguidelinesforrenalcellcarcinoma
AT shenshuhuei asianconferenceontumorablationguidelinesforrenalcellcarcinoma
AT fujimorimasashi asianconferenceontumorablationguidelinesforrenalcellcarcinoma
AT wangyi asianconferenceontumorablationguidelinesforrenalcellcarcinoma